# Study of CM310 Injection in Subjects With Moderate-to-Severe Atopic Dermatitis

> **NCT05715320** · PHASE2 · COMPLETED · sponsor: **Keymed Biosciences Co.Ltd** · enrollment: 160 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **BIOLOGICAL:** CM310

## Key facts

- **NCT ID:** NCT05715320
- **Lead sponsor:** Keymed Biosciences Co.Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-10
- **Primary completion:** 2024-07-18
- **Final completion:** 2024-07-18
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2024-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05715320

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05715320, "Study of CM310 Injection in Subjects With Moderate-to-Severe Atopic Dermatitis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05715320. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*